Accumulation of methylguanidine and changes in guanidino compound levels in plasma, urine, and kidneys of furosemide-treated rats

Metabolism: Clinical and Experimental

Volumn 57, Issue 6, 2008, Pages 802-810

  Levillain, Olivier ^a   Marescau, Bart ^b   Possemiers, Ilse ^b   De Deyn, Peter Paul ^b  

^a UNIVERSITÉ LYON 1   (France)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FUROSEMIDE; GUANIDINE DERIVATIVE; METHYLGUANIDINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DIURESIS; DRUG ACCUMULATION; DRUG SYNTHESIS; KIDNEY; LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SYNTHESIS; URINARY EXCRETION; URINE LEVEL;

ANIMALS; CREATININE; DIURETICS; FUROSEMIDE; GUANIDINES; KIDNEY; MALE; METHYLGUANIDINE; PROPIONIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY; SUCCINATES;

EID: 44049090273     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.01.025     Document Type: Article

References (37)

1. Robin Y., and Marescau B. Natural guanidino compounds. In: Mori A., Cohen B.D., and Lowenthal A. (Eds). Guanidines (1985), Plenum, New York 383-438
2. Levillain O., Marescau B., and De Deyn P.P. Renal handling of guanidino compounds in rat and rabbit. J Physiol London 499 (1997) 561-570
3. Al Banchaabouchi M., Marescau B., Possemiers I., D'Hooge R., Levillain O., and De Deyn P.P. N-G, N-G-dimethylarginine and N-G, N-′G-dimethylarginine in renal insufficiency. Pflugers Arch 439 (2000) 524-531
4. Levillain O. Renal arginine synthesis in mammals. Recent Res Dev Physiol (2003), Research Signpost, Trivandrum 67-83
5. McGuire D.M., Gross M.D., Elde P., and Van Pilsum J.F. Localization of l-arginine-glycine amidinotransferase protein in rat tissues by immunofluorescence microscopy. J Histochem Cytochem 34 (1986) 429-435
6. Gerber G.B., Koszalka T.R., Gerber G., and Altman K.I. Biosynthesis of creatine by the kidney. Nature 196 (1962) 286-287
7. Koszalka T.R., and Bauman A.N. Biosynthesis of creatine by the perfused rat kidney. Nature 212 (1966) 691-693
8. Perez G.O., Epstien M., Rietberg B., and Loutzenhiser R. Metabolism of arginine by the isolated perfused rat kidney. Am J Physiol 235 (1978) F376-F380
9. Saikia T.C. The acute effect of vasopressin upon the composition of the rat renal cortex and medulla. Quart J Exp Physiol 50 (1965) 158-168
10. Valtin H. Sequestration of urea and nonurea solutes in renal tissues of rats with hereditary diabetes insipidus: effect of vasopressin and dehydration on the countercurrent mechanism. J Clin Invest 45 (1966) 377-445
11. Levillain O., Marescau B., Possemiers I., and De Deyn P.P. Dehydration modifies guanidino compound concentrations in the different zones of the rat kidney. Pflugers Arch 444 (2002) 143-152
12. De Deyn P.P., Marescau B., Swartz R.D., Hogaerth R., Possemiers I., and Lowenthal A. Serum guanidino compound levels and clearances in uremic patients treated with continuous ambulatory peritoneal dialysis. Nephron 54 (1990) 307-312
13. Levillain O., Marescau B., and De Deyn P.P. Guanidino compounds metabolism in rats subjected to 20% to 90% nephrectomy. Kidney Int 47 (1995) 464-472
14. De Deyn P.P., Robitaille P., Vanasse M., Qureshi I.A., and Marescau B. Serum guanidino compound levels in uremic pediatric patients treated with hemodialysis or continuous cycle peritoneal dialysis. Nephron 69 (1995) 411-417
15. Marescau B., Nagels G., Possemiers I., De Broe M.E., Becaus I., Billiouw J.M., et al. Guanidino compounds in serum and urine of nondialyzed patients with chronic renal insufficiency. Metabolism 46 (1997) 1024-1031
16. Al Banchaabouchi M., Marescau B., D'Hooge R., Van Marck E., Van Daele A., Levillain O., et al. Biochemical and histopathological changes in nephrectomized mice. Metabolism 47 (1998) 355-361
17. De Deyn P.P., D'Hooge R., Van Bogaert P.P., and Marescau B. Endogenous guanidino compounds as uremic neurotoxins. Kidney Int Suppl 78 (2001) S77-S83
18. Kaissling B., and Stanton B.A. Adaptation of distal tubule and collecting duct to increased sodium delivery. I. Ultrastructure. Am J Physiol 255 (1988) F1256-F1268
19. Wirthensohn G., Lefrank S., Schmolke M., and Guder W.G. Regulation of organic osmolyte concentrations in tubules from rat renal inner medulla. Am J Physiol 256 (1989) F128-F135
20. Kwon E.D., Dooley J.A., Jung K.Y., Andrews P.M., Garcia-Perez A., and Burg M.B. Organic osmolyte distribution and levels in the mammalian urinary bladder in diuresis and antidiuresis. Am J Physiol 271 (1996) F230-F233
21. Marescau B., Deshmukh D.R., Kockx M., Possemiers I., Qureshi I.A., Wiechert P., et al. Guanidino compounds in serum, urine, liver, kidney, and brain of man and some ureotelic animals. Metabolism 41 (1992) 526-532
22. Ceriotti G. Ultramicro determination of plasma urea by reaction with diacetylmonoxime antipyrine without deproteinization. Clin Chem 17 (1971) 400-402
23. Beck F.X., Schmolke M., Guder W.G., Dörge A., and Thurau K. Osmolytes in renal medulla during rapid changes in papillary tonicity. Am J Physiol 262 (1992) F849-F856
24. Knepper M.A., and Rector Jr. F.C. Urinary concentration and dilution. In: Brenner B.M., and Rector Jr. F.C. (Eds). The kidney (1991), W B Sauders, Philadelphia 445-482
25. Yancey P.H., and Burg M.B. Distribution of major organic osmolytes in rabbit kidneys in diuresis and antidiuresis. Am J Physiol 257 (1989) F602-F607
26. Levillain O., Marescau B., Possemiers I., Al Banchaabouchi M., and De Deyn P.P. Influence of 72% injury in one kidney on several organs involved in guanidino compound metabolism: a time course study. Pflugers Arch 442 (2001) 558-569
27. Perez G., and Faluotico R. Creatinine: a precursor of methylguanidine. Experientia 29 (1973) 1473-1474
28. Nagase S., Aoyagi K., Narita M., and Tojo S. Biosynthesis of methylguanidine in isolated rat hepatocytes and in vivo. Nephron 40 (1985) 470-475
29. Nagase S., Aoyagi K., Narita M., and Tojo S. Active oxygen in methylguanidine synthesis. Nephron 44 (1986) 299-303
30. Ienaga K., Nakamura K., Yamakawa M., Toyomaki Y., Matsusra H., Yokozawa T., et al. The use of 13C-labelling to prove that creatinine is oxidized by mammals into creatol and 5-hydroxy-1-methylhydrantoin. J Chem Soc Chem Commun (1991) 509-510
31. Nagase S., Aoyagi K., Sakamoto M., Takemura K., Ishikawa T., and Narita M. Biosynthesis of methylguanidine in the hepatic microsomal fraction. Nephron 62 (1992) 182-186
32. Aoyagi K., Akiyama K., Kuzure Y., Takemura K., Nagase S., Ienaga K., et al. Synthesis of creatol, a hydroxyl radical adduct of creatinine and its increase by puromycin aminonucleoside in isolated rat hepatocytes. Free Radical Res 29 (1998) 221-226
33. Ozasa H., Horikawa S., and Ota K. Methylguanidine synthase from rat kidney is identical to long-chain l-2-hydroxy acid oxidase. Nephron 68 (1994) 279
34. Prandota J. Clinical pharmacology of furosemide in children: a supplement. Am J Ther 8 (2001) 275-289
35. Matsumoto M., and Mori A. Effects of guanidino compounds on rabbit brain microsomal Na+, K+ ATPase. J Neurochem 27 (1976) 635-663
36. D'Hooge R., Pei Y.Q., Marescau B., and De Deyn P.P. Convulsive action and toxicity of uremic guanidino compounds: behavioral assessment and relation to brain concentration in adult mice. J Neurol Sci 112 (1992) 96-105
37. Sorrentino R., and Pinto A. Effect of methylguanidine on rat blood pressure: role of endothelial nitric oxide synthase. Br J Pharmacol 115 (1995) 510-514